Evaluating any emerging health-tech or biosensing enterprise trading under a name like Veri requires careful fundamental analysis of its balance sheet liquidity, commercial traction, and addressable market size. Because early-stage or micro-cap tech equities face severe competition and execution hurdles, what is your specific risk tolerance, investment horizon, and target portfolio allocation? Consulting a licensed financial advisor is recommended before executing trades.